Search
forResearch 10 of 1000+
- Mechanisms and applications of the anti-inflammatory effects of photobiomodulation
- Engineering Robust Ag‐Decorated Polydopamine Nano‐Photothermal Platforms to Combat Bacterial Infection and Prompt Wound Healing
- Pharmacology of anabolic steroids
- Low-Level Light/Laser Therapy Versus Photobiomodulation Therapy
- Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
- New approaches to the physiology of histamine.
- The complex relationship between TFEB transcription factor phosphorylation and subcellular localization
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome
- Induction of the hair growth phase in postnatal mice by localized transient expression of Sonic hedgehog
Community 10 of 937
- Phase 3 Study for PP405 officially posted
- Phoenix 2in1 reaction (min or fin)
- Phase 3 for PP405 will now start in 2027
- So why did the first pyrilutamide phase III fail?
- A minoxidil pill just posted strong phase 3 results. Up to 86% of men improved coverage in six months.
- Experiencing Shedding on Phoenix 2in1 and Nizoral for 9 Months
- Phase 2B trial for PP405 leaked (The study Pelage DOESN'T want you to see)
- Pelage have presented only phase 2a. The rest of phase 2 for PP405 will be presented at a later medical meeting
- I want to prepare a Topical Catalase with Phosphate Buffered Saline Solution.
- Pelage PP405: New Hair Growth from Inactive Follicular Units - Phase 2a results at AAD 2026
Learn 10 of 58
- phenoxyethanol
- Phyllostachys Pubescens
- phosphorus
- Phospholipids
- phenylanine
- Phytosphingosine
- Phytic Acid
- Phytosterols
- Phenaxyethanol
- Phyto-Collagen Complex (Cécred)